av Gerbrand Koster | mai 2, 2024
BUSINESS OPPORTUNITY We have developed a cell line that simultaneously reports on the three arms of the Unfolded Protein Response (UPR). These three evolutionarily conserved signaling arms are activated through the endoplasmic reticulum (ER)-resident IRE1α, PERK and...
av Lise Rødsten | jan 21, 2022
BUSINESS OPPORTUNITY Well-functioning in-vitro models of human osteocytes are lacking. Scientists at the University of Oslo and Oslo University Hospital have developed a method to culture bone cells into osteospheres (bone-like spheroids) in a rotation bioreactor,...
av Aina Rengmark | okt 4, 2021
Business opportunity Scientists at the University of Oslo (Norway) have developed an innovative, scalable directional pump-less perfusion (dPP) organ-on-a-chip (OoC) platform that can transport cell culture media, circulating cells, bacteria and nanoparticles...
av Janncike Kristoffersen | aug 5, 2020
Business opportunity Inven2 offers a sensitive ChIP-seq method for the study of single cells and small pools of cells to reveal where specific proteins or modified histones are bound throughout the genome. This opens up for the study of cell types available only in...
av Kim Larsen | jun 29, 2020
Recent advances in flow and mass cytometers have enabled assessment of more parameters. Furthermore, the use of such technologies in clinical settings and the need for including high numbers of samples in each analysis, makes downstream analysis complicated,...
